Regencell Bioscience Holdings Ltd

NAS:RGC (Hong Kong)  
$ 5.99 -0.11 (-1.8%) 11:08 PM EST
At Loss
P/B:
9.51
Market Cap:
$ 77.95M
Enterprise V:
$ 71.50M
Volume:
13.04K
Avg Vol (2M):
149.32K
Trade In:
Volume:
13.04K
At Loss
Avg Vol (2M):
149.32K

Business Description

Description
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
Name Current Vs Industry Vs History
Cash-To-Debt 92.57
Equity-to-Asset 0.97
Debt-to-Equity 0.01
Debt-to-EBITDA -0.02
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -42.1
3-Year EPS without NRI Growth Rate -45.6
3-Year FCF Growth Rate -71.6
Name Current Vs Industry Vs History
5-Day RSI 45.53
9-Day RSI 46.11
14-Day RSI 47.79
6-1 Month Momentum % -7.19
12-1 Month Momentum % -61.25

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 41.82
Quick Ratio 41.82
Cash Ratio 41.04

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -1
Shareholder Yield % 0.47
Name Current Vs Industry Vs History
ROE % -42.38
ROA % -40.93
ROIC % -115.56
ROC (Joel Greenblatt) % -129.76
ROCE % -46.24

Financials (Next Earnings Date:2025-06-20 Est.)

RGC's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:RGC

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Regencell Bioscience Holdings Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.33
Beta -1.22
Volatility % 210.13
14-Day RSI 47.79
14-Day ATR ($) 0.952474
20-Day SMA ($) 6.54625
12-1 Month Momentum % -61.25
52-Week Range ($) 3.03 - 32.44
Shares Outstanding (Mil) 13.01

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Regencell Bioscience Holdings Ltd Filings

Filing Date Document Date Form
No Filing Data

Regencell Bioscience Holdings Ltd Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Regencell Bioscience Holdings Ltd Frequently Asked Questions

What is Regencell Bioscience Holdings Ltd(RGC)'s stock price today?
The current price of RGC is $5.99. The 52 week high of RGC is $32.44 and 52 week low is $3.03.
When is next earnings date of Regencell Bioscience Holdings Ltd(RGC)?
The next earnings date of Regencell Bioscience Holdings Ltd(RGC) is 2025-06-20 Est..
Does Regencell Bioscience Holdings Ltd(RGC) pay dividends? If so, how much?
Regencell Bioscience Holdings Ltd(RGC) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1